共查询到20条相似文献,搜索用时 15 毫秒
1.
Gian Carlo Ceschel Valentina Bergamante Valeria Calabrese Stefano Biserni Celestino Ronchi A. Fini 《Drug development and industrial pharmacy》2013,39(1):53-61
ABSTRACTThis investigation deals with the development of buccal tablets containing chlorhexidine (CHX), a bis-bis-guanide with antimicrobial and antiseptic effects in the oral cavity, and able to adhere to the buccal mucosa to give local controlled release of drug. A mucoadhesive formulation was designed to swell and form a gel adhering to the mucosa and controlling the drug release into the oral cavity.Some batches of tablets were developed by direct compression, containing different amounts of hydroxypropylmethylcellulose (HPMC) and carbomer; changing the amount ratio of these excipients in formulations, it is possible easily modulate the mucoadhesive effect and release of drug. The in vitro tests were performed using the USP 26/NF paddle apparatus, a specifically developed apparatus, and a modified Franz diffusion cells apparatus. This last method allows a simultaneous study of drug release rate from the tablets and drug permeation through the buccal mucosa.Similar tests have also been carried out on a commercial product, Corsodyl gel®, in order to compare the drug release control of gel with respect to that of the mucoadhesive tablet, as a formulation for buccal delivery of CHX. While the commercial formulation does not appear to control the release, the formulation containing 15% w/w methocel behaves the best, ensuring the most rapid and complete release of the drug, together with a negligible absorption of the active agent as required for a local antiseptic action in the oral cavity. 相似文献
2.
Selected combinations of six model drugs and four hypromellose (USP 2208) viscosity grades were studied utilizing direct compression and in vitro dissolution testing. Experimental HPMC samples with differing particle size distributions (coarse, fine, narrow, bimodal) were generated by sieving. For some formulations, the impact of HPMC particle size changes was characterized by faster drug release and an apparent shift in drug release mechanism when less than 50% of the HPMC passed through a 230 mesh (63 μm) screen. Within the ranges studied, drug release from other formulations appeared to be unaffected by HPMC particle size changes. 相似文献
3.
It is a challenge to deliver water-soluble drug based on hydrophilic matrix to colon because of swelling and erosion of polysaccharides in contact with media. In our study, guar-based hydrophilic matrix tablets containing water-soluble total alkaloids of Sophora alopecuroides prepared by wet granulation technique were evaluated. A novel method was established to investigate the changes of swelling and volume for guar-based tablets in undynamic state, which generally showed a rapid swelling and volume change in the first 9 h, then the hydrated speed slowed down. On the other hand, the influence of different pH of the media on water uptake and erosion of various guar-based formulations in dynamic state indicated that the hydrated constants in simulated gastric fluid (SGF) was higher than that in SIF, which followed varied mechanism of water penetration by fitting Davidson and Peppas model. The extent of erosion was between 22.4 and 32.6% in SIF within 360 min. In vitro sophoridine release studies in successive different mimicking media showed that the guar matrix tablets released 13.5–25.6% of sophoridine in the first 6 h; therefore it was necessary to develop the bilayer matrix tablet by direct-compressing coating 100 mg guar granula on core tablet. The initial release of coated tablet was retarded and the bilayer matrix tablet was suitable for colon target. 相似文献
4.
Controlled Release of Mangiferin Using Ethylene Vinyl Acetate Matrix for Antioxidant Packaging
下载免费PDF全文
![点击此处可从《Packaging Technology and Science》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Rungkan Boonnattakorn Vanee Chonhenchob Muhammad Siddiq Sher Paul Singh 《Packaging Technology and Science》2015,28(3):241-252
This study investigated the use of ethylene vinyl acetate (EVA) matrix in controlled release packaging. Mangiferin, having high antioxidant activity, was incorporated into the EVA matrix with different vinyl acetate (VA) contents. Mangiferin release rate increased with increasing VA content (or decreasing crystallinity). Linear relationship between mangiferin release rate and VA content was observed in the range of 18–40% VA. The diffusion coefficients of mangiferin released from the EVA matrices containing 12%, 18%, 25% and 40% VA were 0.482, 0.512, 2.81 and 2.88 (×10?14 m2/s), respectively. The enhancement factors of about 22‐fold and sevenfold were observed in the 12% and 18% VA matrices, respectively, when using triethyl citrate as a plasticizer. EVA film containing 40% VA had the highest antioxidant activity (81.90% radical scavenging capacity, (RSC)) because the highest amount of mangiferin was released in the food simulant (84.66 µg/ml). Addition of mangiferin in the polymer matrices had no significant (p > 0.05) effect on thermal and barrier properties of the films but decreased tensile strength and Young's modulus. The results of this study demonstrated that EVA matrices with varying degree of VA could potentially be used to control mangiferin release rate for antioxidant packaging. Copyright © 2014 John Wiley & Sons, Ltd. 相似文献
5.
R. Panchagnula A. Gupta S. Kandavilli M. V. S. Varma 《Drug development and industrial pharmacy》2013,39(6):669-675
AbstractDrug release from controlled-release (CR) matrix tablets involves the permeation and diffusion of water through the system. In this study, a new methodology is proposed for the measurement of water permeation and simultaneous drug release from the inert, non-swellable CR matrix tablet of diltiazem (DLT) and a correlation is made between these two processes. Cylindrical matrices were readily prepared by direct compression of pellets obtained by extrusion-spheronization. Water transport was studied using tritiated water (HTO) as a permeant in a Franz-diffusion cell and simultaneously drug release was measured. Further, dissolution was performed on USP XXI/XXII dissolution apparatus I using demineralized water. Matrices showed a steady water-uptake up to 6 h and the steady state for HTO permeation lasting from 6-h to 24-h Flux of water permeated and flux of drug released correlated well. Thus, HTO permeation through the matrix tablet and the proposed methodology can be used as a tool and/or surrogate marker for evaluation of controlled release matrix tablets. This methodology can be coined as “high-throughput” in terms of amount of labor and resources required in comparison to that of dissolution. 相似文献
6.
André Rolim Baby Carlos Alberto Haroutiounian-Filho Fernanda Daud Sarruf Claudinéia Aparecida Sales de Oliveira Pinto Telma Mary Kaneko Maria Valéria Robles Velasco 《Drug development and industrial pharmacy》2013,39(3):272-282
Rutin, one of the major flavonoids found in an assortment of plants, was reported to act as a sun protection factor booster with high anti-UVA defense, antioxidant, antiaging, and anticellulite, by improvement of the cutaneous microcirculation. This research work aimed at evaluating the rutin in vitro release from semisolid systems, in vertical diffusion cells, containing urea, isopropanol and propylene glycol, associated or not, according to the factorial design with two levels with center point. Urea (alone and in association with isopropanol and propylene glycol) and isopropanol (alone and in association with propylene glycol) influenced significant and negatively rutin liberation in diverse parameters: flux (μg/cm2.h); apparent permeability coefficient (cm/h); rutin amount released (μg/cm2); and liberation enhancement factor. In accordance with the results, the presence of propylene glycol 5.0% (wt/wt) presented statistically favorable to promote rutin release from this semisolid system with flux?=?105.12?±?8.59 μg/cm2.h; apparent permeability coefficient?=?7.01?±?0.572 cm/h; rutin amount released?=?648.80?±?53.01 μg/cm2; and liberation enhancement factor?=?1.21?±?0.07. 相似文献
7.
Amir Masoud Vali Taiebeh Toliyat Bijan Shafaghi Simin Dadashzadeh 《Drug development and industrial pharmacy》2013,39(1):10-23
This study reports the development of liposomal system for a potent antitumor drug, topotecan. To achieve this goal conventional and PEGylated liposomes were prepared according to a factorial design by hydration method followed by extrusion. Parameters such as type of lipid, percentage of cholesterol, percentage of phosphatidylglycerols, percentage of polyethylene glycol (PEG)-lipids, and drug to lipid molar ratio were considered as important factors for the optimizing the entrapment and retention of topotecan inside the liposomes. The size and zeta-potential of the PEGylated and conventional liposomes were measured by particle size analyzer and zeta-potentiometer, respectively. The stability and release characteristics of PEGylated liposome loaded topotecan were compared with conventional liposomes and free topotecan.The optimized PEGylated [distearoyl phosphatidylcholine (DSPC)/cholesterol/ distearoyl phosphatidylglycerol (DSPG)/ distearoyl phosphatidylethanolamine-PEG2000 (DSPE-PEG2000); 7:7:3:1.28] and related conventional [DSPC/cholesterol/DSPG; 7:7:3] liposomes showed a narrow size distribution with a polydipersity index of 0.15 and 0.10, an average diameter of 103.0 ± 13.1 and 95.2 ± 11.10 nm, and with drug loading of 11.44 and 6.21%, respectively. Zeta-potential was ?10 ± 2.3 and ?22 ± 2.8 mV for PEGylated and conventional liposomes, respectively. The results of stability evaluation showed that the lactone ring of topotecan was notably preserved upon liposome encapsulation. PEGylated liposomes containing topotecan showed a significant decrease (P < 0.001) in release rate in comparison with conventional leptosomes. These results indicate the suitability of PEGylated liposomes in controlling topotecan release.The prepared liposomes (especially PEGylated liposomes) as those described here may be clinically useful to stabilize and deliver topotecan for the treatment of cancer. 相似文献
8.
Carla M. Lopes José Manuel Sousa Lobo Paulo Costa João F. Pinto 《Drug development and industrial pharmacy》2013,39(1):95-106
ABSTRACTDirectly compressed mini tablets were produced containing either hydroxypropylmethylcellulose (HPMC) or ethylcellulose (EC) as release controlling agent. The dynamics of water uptake and erosion degree of polymer were investigated. By changing the polymer concentration, the ibuprofen release was modified. In identical quantities, EC produced a greater sustaining release effect than HPMC. Different grades of viscosity of HPMC did not modify ibuprofen release. For EC formulations, the contribution of diffusion was predominant in the ibuprofen release process. For HPMC preparations, the drug release approached zero-order during a period of 8 h. For comparative purposes, tablets with 10 mm diameter were produced. 相似文献
9.
Sustained-release micro-/nanospheres of the ketorolac tromethamine (KTC) were prepared using four different techniques viz., single emulsion solvent evaporation, high pressure homogenization, spray drying, and using a microreactor. Ethyl cellulose (EC) was used as an encapsulating agent for the preparation of sustained-release micro-/nanospheres of KTC. The Plackett–Burman design was employed for design of the experiments. The resulting micro-/nanospheres were characterized for their size, morphology, encapsulation efficiency, and in vitro drug release performance. Interactions between the KTC and EC were quantified by Fourier transform infrared (FTIR) spectroscopy and X-ray powder diffractometry (XRPD). Particle morphology characterization was performed using field emission scanning electron microscopy. The micro-/nanospheres showed encapsulation efficiency of 42.34–89.33% by the solvent evaporation technique, 76.36–91.13% by the high-pressure homogenization technique, 70.74–79.68% by spray drying, and 79.00–89.49% by the microreactor technique. The micro-/nanospheres were found to be spherical and oval with smooth surface. The FTIR analysis confirmed no interaction of KTC with EC polymer. The XRPD analysis revealed good dispersion of the drug within the micro-/nanospheres formulation. Sustained KTC release profile over 12?h was achieved successfully by EC polymer. In conclusion, EC sustained-release micro-/nanospheres containing KTC can be prepared successfully using different techniques. 相似文献
10.
通过纳米沉淀法制备了一种粒径均一的琼脂糖醋酸酯纳米粒子,并对影响粒径的相关因素进行了研究。结果表明,纳米粒子分别随着二甲基亚砜(DMSO)与水的比率、姜黄素含量及琼脂糖醋酸酯(AA)的浓度的增加而增大,随转速的增加而下降,异丙醇和聚乙烯醇(PVA)浓度也有一定的影响。同时研究了载体对姜黄素的包载情况及缓释行为。结果显示,无异丙醇组中姜黄素载药率和包封率均比异丙醇组中的高。但两组都表明,随着姜黄素的含量增加,载药粒子的载药率不断增加,包封率不断降低。载药粒子大大延长了姜黄素的缓释时间。获得的琼脂糖醋酸酯纳米粒子可望用于姜黄素的控释。 相似文献
11.
This article reports the exploitation of novel hydrophilic excipient, that is, mucilage from Hibiscus rosasinensis Linn, for the development of sustained release tablet. Swelling ratio and flow properties analyses of dried mucilage powder were carried out. A 32 full factorial design was used. In factorial design, amounts of dried mucilage and dibasic calcium phosphate (DCP) were taken as independent factors and percentage drug release in 60 and 300 min and time for 80% drug release as dependent variables. Matrix tablet containing dried mucilage and diclofenac sodium (DS) was prepared through direct compression techniques. DS tablets were evaluated for hardness, friability, weight variation, in vitro drug release and water uptake, and mass loss study. The dried mucilage powder shows superior swelling capacity and excellent flow properties. Prepared tablets have acceptable hardness, friability, and uniformity in weight. It was found that batch HD8 fulfills all selected criteria. Drug release kinetics from these formulations corresponded best to the zero-order kinetics. Water uptake was independent whereas mass loss was dependent on agitation speed. The concept of similarity factor (f2) was used to prove similarity of dissolution profile in distilled water and phosphate buffer and was found to be 90.68. It was concluded that mucilage can be used as release-retarding agent for 12 h when the drug–mucilage ratio was 1:1.5. So, matrix tablet containing dried mucilage is most suitable for sustained release of DS. 相似文献
12.
以果胶为原料,采用机械活化法改性,研究了机械活化时间对果胶水溶性和溶胀性的影响,制备了骨架片,探讨了粘合剂、钙盐种类、机械活化时间、载药量和压片压力对骨架片制备的影响,通过BSA含量的测定,研究了机械活化骨架片的释放特性。机械活化改性,降低了果胶的水溶性和溶胀度;骨架片的最佳工艺,0.025g MA 8h,0.008g BSA,0.025g甲基纤维素,0.008g CaSO4与0.001g硬脂酸镁,压片压力8kg·mm-2。机械活化改性果胶骨架片具有更高的化学活性,能使骨架片外表层迅速形成致密凝胶层,与水溶性小的CaSO4形成果胶钙沉淀,有效地减缓水分在骨架片中的扩散。药物在凝胶层膜内溶解并饱和,通过自由扩散作用向膜外扩散。而薄的凝胶层中浓度梯度大,药物快速释放到介质中,表现为药物的初始释放度大。机械活化改性果胶致密而薄的凝胶层和果胶钙沉淀的egg-box空间网状结构大大降低了溶剂的扩散作用,药物释放速度减慢并最终趋于稳态,表现为骨架片释药速度的恒定。 相似文献
13.
水凝胶作为性能良好的载体,在药物的控释、组织工程等领域有着广泛的应用。壳聚糖是一类天然的带正电荷的碱性多糖,由其形成的水凝胶具有较好的生物相容性、生物降解性、抗菌和低细胞毒性,因此,壳聚糖水凝胶有着良好的生物应用前景。本文综述了壳聚糖水凝胶的制备方法(包括物理交联法和化学交联法),在物理交联法部分着重介绍了离子化合物及聚电解质分子与壳聚糖通过离子交联形成水凝胶,以及利用分子链间的疏水作用形成壳聚糖水凝胶的方法;而在化学交联法部分介绍了合成壳聚糖水凝胶的化学手段,包括交联剂、光照辐射和酶的使用。继而概述了壳聚糖水凝胶在药物缓释应用方面的研究进展,包括温度、pH值和电场响应的药物控释体系。最后展望了壳聚糖水凝胶未来的发展前景。 相似文献
14.
The emerging new fixed dose combination of metformin hydrocholride (HCl) as sustained release and glipizide as immediate release were formulated as a bilayer matrix tablet using hydroxy propyl methyl cellulose (HPMC) as the matrix-forming polymer, and the tablets were evaluated via in vitro studies. Three different grades of HPMC (HPMC K 4M, HPMC K 15M, and HPMC K 100M) were used. All tablet formulations yielded quality matrix preparations with satisfactory tableting properties. In vitro release studies were carried out at a phosphate buffer of pH 6.8 with 0.75% sodium lauryl sulphate w/v using the apparatus I (basket) as described in the . The release kinetics of metformin were evaluated using the regression coefficient analysis. There was no significant difference in drug release for different viscosity grade of HPMC with the same concentration. Tablet thus formulated provided sustained release of metformin HCl over a period of 8 hours and glipizide as immediate release. 相似文献
15.
Ouyang Defang Nie Shufang Li Wei Guo Hong Liu Hui Pan Weisan 《Drug development and industrial pharmacy》2013,39(7):677-685
A system that can deliver multi-drugs at a prolonged rate is very important to the treatment of various chronic diseases such as diabetes, asthma, and heart disease. Two controlled-release systems, which exhibited similar release profiles of metformin and glipizide, i.e., elementary osmotic pump tablets (EOP) and bilayer hydrophilic matrix tablet (BT), were designed. The effects of pH and hydrodynamic conditions on drug release from two formulations were investigated. It was found that both drug releases from EOP were not sensitive to dissolution media pH and hydrodynamics change, while the release of glipizide from BT was influenced by the stirring rate. Moreover, in vivo evaluation was performed, relative to the equivalent dose of conventional metformin tablet and glipizide tablet, by a three-crossover study in six Beagle dogs. Cumulative percent input in vivo was compared to in vitro release profiles. The linear correlations of metformin and glipizide between fraction absorbed in vivo and fraction dissolved in vitro were established for EOP—a true zero-order release formula, whereas only nonlinear correlations were obtained for BT. In conclusion, drug release from EOP was both independent of in vitro and in vivo conditions, where the best sustained release effect was achieved, whereas the in vitro dissolution test employed for BT needed to be further optimized to be biorelevant. 相似文献
16.
以戊二醛为交联剂,制备了pH敏感性明胶-果胶水凝胶(GT-PT)和明胶-辛基果胶水凝胶(GT-OPT),研究了交联剂用量、温度、pH值对凝胶溶胀性能的影响及溶胀-消溶胀性能。结果表明,当温度在30~60℃时,凝胶的溶胀率随温度的升高而增大;且具有明显的pH敏感性,碱性条件下的溶胀率大于酸性条件下的溶胀率;不同pH值条件下,明胶-果胶水凝胶具有"形状记忆"功能。包埋在水凝胶中的牛血清蛋白在pH=1.0时的释药率大于pH=7.8和pH=9.18时的释药率。此类水凝胶有望用于蛋白质的pH值及温度控制释放。 相似文献
17.
Padma V. Devarajan Ganeshchandra S. Sonavane 《Drug development and industrial pharmacy》2013,39(2):101-111
ABSTRACTThe aim of this study was to formulate and optimize gliclazide-loaded Eudragit nanoparticles (Eudragit L100 and Eudragit RS) as a sustained release carrier with enhanced efficacy. Eudragit L 100 nanoparticles (ELNP) were prepared by controlled precipitation method whereas Eudragit RSPO nanoparticles (ERSNP) were prepared by solvent evaporation method. The influence of various formulation factors (stirring speed, drug:polymer ratio, homogenization, and addition of surfactants) on particle size, drug loading, and encapsulation efficiency were investigated. The developed Eudragit nanoparticles (L100 and RS) showed high drug loading and encapsulation efficiencies with nanosize. Mean particle size altered by changing the drug:polymer ratio and stirring speed. Addition of surfactants showed a promise to increase drug loading, encapsulation efficiency, and decreased particle size of ELNP as well as ERSNP. Dissolution study revealed sustained release of gliclazide from Eudragit L100 as well as Eudragit RSPO NP. SEM study revealed spherical morphology of the developed Eudragit (L100 and RS) NP. FT-IR and DSC studies showed no interaction of gliclazide with polymers. Stability studies revealed that the gliclazide-loaded nanoparticles were stable at the end of 6 months. Developed Eudragit NPs revealed a decreased tmin (ELNP), and enhanced bioavailability and sustained activity (ELNP and ERSNP) and hence superior activity as compared to plain gliclazide in streptozotocin induced diabetic rat model and glucose-loaded diabetic rat model. The developed Eudragit (L100 and RSPO) NP could reduce dose frequency, decrease side effects, and improve patient compliance. 相似文献
18.
以自制Fe3O4磁性纳米为磁性靶向核,在乳液体系中制备壳聚糖/三聚磷酸钠/5-Fu磁性壳聚糖纳米载药体(TCF),经一定比例的PHB和PEG混合外包覆,得到载药率为16.56%的磁性纳米微囊(PTCF),通过红外光谱、x-射线粉末衍射、透射电镜和振动磁强计表征,结果显示,TCF、PTCF分别为粒径15nm和20nm均匀颗粒,25℃时的矫顽力和剩磁均趋于零,表现出超顺磁性;体外释药行为显示,PTCF无突释现象,释药速率随PHB和PEG用量可控,具备磁靶向控释药物的潜在性质。 相似文献
19.
Yuh-Tyng Huang Tong-Rong Tsai Chun-Jen Cheng Thau-Ming Cham Tsun-Fwu Lai Wen-Ho Chuo 《Drug development and industrial pharmacy》2013,39(11):1183-1191
Pyridostigmine bromide (PB), a highly hygroscopic drug was selected as the model drug. A sustained-release (SR) tablet prepared by direct compression of wet-extruded and spheronized core pellets with HPMC excipients and exhibited a zero-order sustained release (SR) profile. The 23 full factorial design was utilized to search an optimal SR tablet formulation. This optimal formulation was followed zero-order mechanism and had specific release rate at different time intervals (released % of 1, 6, and 12 hr were 15.84, 58.56, and 93.10%). The results of moisture absorption by Karl Fischer meter showed the optimum SR tablet could improve the hygroscopic defect of the pure drug (PB). In the in vivo study, the results of the bioavailability data showed the Tmax was prolonged (from 0.65 ± 0.082 hr to 4.83 ± 1.60 hr) and AUC0–t (from 734.88 ± 230.68 ng/ml.hr to 1153.34 ± 488.08 ng/ml.hr) and was increased respectively for optimum PB-SR tablets when compared with commercial immediate release (IR) tablets. Furthermore, the percentages of in vitro dissolution and in vivo absorption in the rabbits have good correlation. We believe that PB-SR tablets designed in our study would improve defects of PB, decrease the frequency of administration and enhance the retention period of drug efficacy in vivo for personnel exposed to contamination situations in war or terrorist attacks in the future. 相似文献
20.
《Drug development and industrial pharmacy》2013,39(12):1309-1313
The aim of this work was to study the influence of the concentration and molecular weight of poly(DL-lactide) (PLA) on the characteristics and in vivo biological activity of protein-loaded microspheres. At the same time, an attempt was made to achieve further optimization of the formulation. In the study, insulin was chosen as a model of protein drugs. Nine formulations of injectable insulin-loaded PLA microspheres were prepared using an emulsification and solvent evaporation process according to a factorial design. The trapping efficiency, drug loading, and the drop percentages of blood glucose levels at 24 hr and 72 hr in mice were used to evaluate the formulations. The results showed that PLA molecular weight and, especially, PLA concentration exerted influences on the characteristics and in vivo biological activity of insulin-loaded microspheres. The drug-trapping efficiency increased with the increase of the polymer concentration. The drug loading decreased with the increase of the polymer concentration and was not obviously affected by PLA molecular weight. The drop percentage of blood glucose level at 24 hr increased with the increase of polymer concentration and molecular weight. At 72 hr, the drop percentages of blood glucose levels were slightly increased with the increase of PLA concentration and then significantly decreased after the PLA concentration was above 150 mg/ml. An optimized formulation was prepared with PLA-10k at a concentration of 200 mg/ml. The experimental values of the response variables were close to the predicted values. The results suggest that the in vivo release behavior should be taken into consideration in the design of protein-loaded PLA microspheres. 相似文献